3522集团新网站

分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Atorvastatin-Driven Methuosis in Glioblastoma: A Biomimetic Nanodrug for Targeted Tumor Therapy

Xinyan Hao, Yucheng Tang, Wenjie Xu, Ming Wang, Jiayi Liu, Haitao Yang, Pengcheng Sun, Dehua Liao, Xiongbin Hu, Tiantian Tang, Hai Huang, Xinying Liu, Daxiong Xiang, Junyong Wu

Journal:ACS Nano

IF:16

DOI:10.1021/acsnano.5c15615

PMID:

Published:2026-04-03

research field:肿瘤学药物递送癌症免疫治疗纳米医学神经肿瘤学

Abstract

Glioblastoma (GBM) is a highly malignant brain tumor. The immunosuppressive microenvironment and resistance to chemotherapy-induced apoptosis pose significant challenges for treatment. In this study, we found that atorvastatin calcium (AC) can effectively induce methuosis in GBM cells, suggesting its potential as a therapeutic candidate for GBM treatment. To address the challenge of crossing the blood–brain barrier (BBB) and enhance drug delivery efficiency, we synthesized AC nanoparticles stabilized through dopamine polymerization, achieving high drug-loading efficiency. Moreover, the nanoparticles were coated with PD-1-engineered BV2 cell membranes and further modified with Angiopep-2 peptides to facilitate BBB crossing and effective accumulation at the tumor site. In vitro experiments confirmed the cytotoxicity and induction of methuosis in GBM cells by AP@CM-Ang, accompanied by the release of immune-stimulatory factors. In vivo experiments demonstrated that the nanodrug significantly enhanced tumor targeting, effectively inhibited tumor growth, and increased immune cell activation, validating its potential as a promising and safe strategy for GBM treatment.

本文使用的Yeasen产品

购物车
客服
转染试用